pregnenes - CISMeF

Preferred Label : pregnenes;

MeSH definition : Unsaturated derivatives of PREGNANES.;

MeSH annotation : do not confuse with PREGNANES;

Wikipedia link : https://en.wikipedia.org/wiki/Pregnenes;

Is substance : O;

Détails

Origin ID

D011283;

UMLS CUI

C0033014;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Ne pas confondre avec
- pregnanes [MeSH Descriptor]
Record concept(s)
- pregnenes [MeSH concept]
Related MeSH Supplementary Concept(s)
- (7alpha,17alpha)-17-hydroxy-7-methyl-19-nor-17-pergen-5(10)-en-20-yn-3-one steroid [MeSH Supplementary Concept]
- 11,20-dihydroxy-4-pregnene-3-one-21-oic acid [MeSH Supplementary Concept]
- 15 beta,17 alpha,20 beta-trihydroxy-4-pregnen-3-one [MeSH Supplementary Concept]
- 16 beta-methyl-5 alpha-delta 9(11)-pregnene-3 beta,17 alpha,21-triol-20-one-3 beta,21-diacetate [MeSH Supplementary Concept]
- 17alpha-acetoxy-3beta-hydroxy-6-methylene-pregna-4-en-20-one [MeSH Supplementary Concept]
- 2'-(2-fluoro-4-pyridyl)-11beta,17,21-trihydroxy-16alpha-methyl-20-oxo-pregn-4-eno(3,2-c)pyrazole [MeSH Supplementary Concept]
- 2'-(2-fluoro-5-pyridyl)-11,17,21-trihydroxy-16-methyl-20-oxopregn-4-eno(3,2-c)pyrazole [MeSH Supplementary Concept]
- 20,20-methyleneoxy-3-oxo-4-pregnen-21-acid methylester [MeSH Supplementary Concept]
- 20-(N,N-dimethylamino)-3-(2-methyl-2-butenamido)pregn-5-en-4-one [MeSH Supplementary Concept]
- 20-hydroxy-21,21,21,-trifluoropregn-4-en-3-one [MeSH Supplementary Concept]
- 20-hydroxy-3-oxo-4-pregnen-21-carboxylic acid [MeSH Supplementary Concept]
- 20-methyl-20-(2-hydroxyethoxy)-5-pregnene-3 beta,17 alpha-diol [MeSH Supplementary Concept]
- 20-methylpregn-5-en-3 beta-ol [MeSH Supplementary Concept]
- 20-methylpregn-5-ene-3,20-diol [MeSH Supplementary Concept]
- 20-phenyl-5-pregnene-3 beta,20-diol [MeSH Supplementary Concept]
- 22-amino-23,24-bisnor-5-cholen-3-ol [MeSH Supplementary Concept]
- 22-thio-23,24-bisnor-5-cholen-3-ol [MeSH Supplementary Concept]
- 23,24-dinor-5-cholene-3,21-diol [MeSH Supplementary Concept]
- 3,11,12,20 tetra-O-acetyl-pregn-5-ene-14beta-ol [MeSH Supplementary Concept]
- 3,17,20-trihydroxy-4-methylpregn-8-en-7-one [MeSH Supplementary Concept]
- 3-hydroxy-11-oxopregn-17(20)-ene-21-nitrile [MeSH Supplementary Concept]
- 3-oxo-4-pregnene-20-carboxylic acid [MeSH Supplementary Concept]
- 3beta,17-dihydroxy-20-oxopregn-5-en-19-al-19-(O-carboxymethyl)oxime [MeSH Supplementary Concept]
- 3beta-acetoxy-18-dimethoxy-20-oxo-delta(16)-5alpha-pregnene [MeSH Supplementary Concept]
- 3beta-tert-butyldimethylsilyloxy-19-hydroxy-19-vinyl-16alpha,17alpha-cyclohexapregn-5-en-20-one [MeSH Supplementary Concept]
- 4-pregnene-3 alpha,20 alpha-diol [MeSH Supplementary Concept]
- 5-dehydromalouetine [MeSH Supplementary Concept]
- 5-pregnen-3,20-diol glucoside [MeSH Supplementary Concept]
- 5-pregnene-3 beta,17 alpha,20 alpha-triol [MeSH Supplementary Concept]
- 5alpha-pregn-6-ene-3beta,17alpha,20(S)-triol-20-O-beta-D-digitoxopyranoside [MeSH Supplementary Concept]
- 6alpha-methylpregn-4-ene-3,11,20-trione [MeSH Supplementary Concept]
- 7beta,8-epoxy-3beta-hydroxy-4,4,14alpha-trimethyl-12,15, 20-trioxo-5α-pregn-9(11)-ene [MeSH Supplementary Concept]
- 8beta-hydroxy-3,20-dioxopregn-4,6-diene [MeSH Supplementary Concept]
- 9,10-seco-4-pregnene-3,9,20-trione [MeSH Supplementary Concept]
- GG-52 compound [MeSH Supplementary Concept]
- HS 974 [MeSH Supplementary Concept]
- HS 998 [MeSH Supplementary Concept]
- S007-1261 [MeSH Supplementary Concept]
- SC 27169 [MeSH Supplementary Concept]
- TX 3047 [MeSH Supplementary Concept]
- anagestone [MeSH Supplementary Concept]
- anasteroside B [MeSH Supplementary Concept]
- asterogenol [MeSH Supplementary Concept]
- asterone [MeSH Supplementary Concept]
- gagaminine [MeSH Supplementary Concept]
- glycoside H2 [MeSH Supplementary Concept]
- guneribone [MeSH Supplementary Concept]
- holaphyllaminol [MeSH Supplementary Concept]
- irehdiamine A [MeSH Supplementary Concept]
- methyl-1alpha, 7alpha-dihydroxy-3-oxopregn-4-en-21-oate [MeSH Supplementary Concept]
- penupogenin [MeSH Supplementary Concept]
- periplocoside A [MeSH Supplementary Concept]
- periplocoside B [MeSH Supplementary Concept]
- periplocoside C [MeSH Supplementary Concept]
- periplocoside D [MeSH Supplementary Concept]
- periplocoside E [MeSH Supplementary Concept]
- periplocoside F [MeSH Supplementary Concept]
- periplocoside J [MeSH Supplementary Concept]
- periplocoside K [MeSH Supplementary Concept]
- periplocoside O [MeSH Supplementary Concept]
- periplocoside P [MeSH Supplementary Concept]
- periplocoside X [MeSH Supplementary Concept]
- polypodoside A [MeSH Supplementary Concept]
- pregna-20-en-3-O-alpha-fucopyranoiside [MeSH Supplementary Concept]
- sarcostin [MeSH Supplementary Concept]
- withangulatin A [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients